Among patients with high cholesterol receiving moderate- or high-intensity statin therapy, the addition of the human monoclonal antibody evolocumab resulted in additional lowering of low-density lipoprotein cholesterol (LDL-C) ...
May 13, 2014
0
0
The search continues for an agent that increases high-density lipoprotein (HDL) and reduces arterial plaque, after the experimental apolipoprotein A1 (apoA1) inducer, RVX-208 failed to do so in the ApoA1 Synthesis Stimulation ...
Sep 2, 2013
0
0
The type of healthcare reimbursement system influences the achievement of cholesterol targets, reveals research presented at ESC Congress 2013 today by Dr. Anselm Kai Gitt from Germany. The subanalysis of the Dyslipidemia ...
Sep 1, 2013
0
0
People who stop taking cholesterol drugs may be at an increased risk for developing Parkinson's disease, according to research that appears in the July 24, 2013, online issue of Neurology, the medical journal of the American ...
Jul 24, 2013
0
0
(HealthDay)—Initiating statin therapy is associated with an increased risk of type 2 diabetes, which is not explained by differential survival, according to a study published in the May issue of Diabetes Care.
Jun 17, 2013
0
0
The side effects of Australia's most commonly prescribed cholesterol-lowering drugs may outweigh the benefits in older people, a new clinical review has found.
Jun 3, 2013
0
0
(Medical Xpress)—It's likely if you're sick, your doctor is more inclined to prescribe a brand name drug in place of its generic equivalent. Or maybe you would rather pick up some Advil for that headache, instead of the ...
May 27, 2013
0
0
Treatment with high potency statins (especially atorvastatin and simvastatin) may increase the risk of developing diabetes, suggests a paper published today in BMJ.
May 23, 2013
0
0
(HealthDay)—Different types and doses of statins seem to correlate with distinct risks of developing new-onset diabetes mellitus (DM), according to a meta-analysis published in the April 15 issue of The American Journal ...
Apr 11, 2013
0
0
Colorectal cancer is the second leading cause of cancer-related deaths in the United States. Once colorectal cancer has spread to other parts of the body, only 11 percent of patients will survive five years from the date ...
Apr 7, 2013
0
0
